Teva warns on profit as drugmaker's problems deepen

JERUSALEM (Reuters) - Teva Pharmaceutical Industries, the world's biggest generic medicine maker, said it would miss 2017 profit forecasts due to competition in the U.S. market and weakening sales of its multiple sclerosis drug Copaxone, hammering its shares
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news